Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P A Fischer

Showing results (51-60 of 133) with videos related to

Pageof 14
Sort By:
Acta Neurologica Scandinavica|June 5, 1998
Glutamine synthetase activity in patients with Parkinson's diseaseF Zipp, L Demisch, A Derouiche, et al.
Journal of Neural Transmission|January 1, 1985
Mesulergine and bromocriptine in long-term treatment of advanced parkinsonismH Baas, E Schneider, P A Fischer, et al.
Fortschritte Der Neurologie-Psychiatrie|May 1, 1981
[Mortality in Parkinson's disease and its modification by levodopa (author's transl)]E Schneider, P A Fischer, P Jacobi, et al.
Fortschritte Der Neurologie-Psychiatrie|June 1, 1984
[Exogenous psychoses in Parkinson syndrome. Frequency and causal conditions]E Schneider, P A Fischer, P Jacobi, et al.
Die Medizinische Welt|November 9, 1973
[Combination therapy of Parkinson's syndrome using L-dopa and a decarboxylase inhibitor]P A Fischer, E Schneider, P Jacobi, et al.
Archiv Fur Psychiatrie Und Nervenkrankheiten|March 19, 1973
[Comparison of the effect of L-Dopa and of an L-Dopa+decarboxylase inhibitor combination in Parkinson's disease]E Schneider, P A Fischer, P Jacobi, et al.
Journal of Neurology|December 1, 1993
Interleukin-2, soluble interleukin-2-receptor, neopterin, L-tryptophan and beta 2-microglobulin levels in CSF and serum of patients with relapsing-remitting or chronic-progressive multiple sclerosisM Ott, L Demisch, W Engelhardt, et al.
Der Nervenarzt|March 1, 1973
[Longtime study on the effects of L-dopa therapy in parkinsonism]P A Fischer, E Schneider, P Jacobi, et al.
Medizinische Klinik|August 12, 1977
[Bencyclane (Fludilat) in the therapy of local cerebrovascular disorders]K Kohlmeyer, E Schneider, P A Fischer, et al.
Deutsche Medizinische Wochenschrift (1946)|August 24, 1984
[Combined treatment of the early stages of Parkinson's syndrome with bromocriptine and levodopa. The results of a multicenter study]P A Fischer, H Przuntek, M Majer, et al.
Pageof 14

Showing results (51-60 of 133) with videos related to

Sort By:
Pageof 14
Acta Neurologica Scandinavica|June 5, 1998
Glutamine synthetase activity in patients with Parkinson's diseaseF Zipp, L Demisch, A Derouiche, et al.
Journal of Neural Transmission|January 1, 1985
Mesulergine and bromocriptine in long-term treatment of advanced parkinsonismH Baas, E Schneider, P A Fischer, et al.
Fortschritte Der Neurologie-Psychiatrie|May 1, 1981
[Mortality in Parkinson's disease and its modification by levodopa (author's transl)]E Schneider, P A Fischer, P Jacobi, et al.
Fortschritte Der Neurologie-Psychiatrie|June 1, 1984
[Exogenous psychoses in Parkinson syndrome. Frequency and causal conditions]E Schneider, P A Fischer, P Jacobi, et al.
Die Medizinische Welt|November 9, 1973
[Combination therapy of Parkinson's syndrome using L-dopa and a decarboxylase inhibitor]P A Fischer, E Schneider, P Jacobi, et al.
Archiv Fur Psychiatrie Und Nervenkrankheiten|March 19, 1973
[Comparison of the effect of L-Dopa and of an L-Dopa+decarboxylase inhibitor combination in Parkinson's disease]E Schneider, P A Fischer, P Jacobi, et al.
Journal of Neurology|December 1, 1993
Interleukin-2, soluble interleukin-2-receptor, neopterin, L-tryptophan and beta 2-microglobulin levels in CSF and serum of patients with relapsing-remitting or chronic-progressive multiple sclerosisM Ott, L Demisch, W Engelhardt, et al.
Der Nervenarzt|March 1, 1973
[Longtime study on the effects of L-dopa therapy in parkinsonism]P A Fischer, E Schneider, P Jacobi, et al.
Medizinische Klinik|August 12, 1977
[Bencyclane (Fludilat) in the therapy of local cerebrovascular disorders]K Kohlmeyer, E Schneider, P A Fischer, et al.
Deutsche Medizinische Wochenschrift (1946)|August 24, 1984
[Combined treatment of the early stages of Parkinson's syndrome with bromocriptine and levodopa. The results of a multicenter study]P A Fischer, H Przuntek, M Majer, et al.
Pageof 14